약학회지
YAKHAK HOEJI
ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Table. 3.

Table. 3.

The status of approval and development of biosimilar recombinant products (April 2018)

Scope Number of approved products Number of products under development Remarks
Hormone 28 8 Including Enbrel
Cytokine 57 22
Enzyme 5 0
Monoclonal antibody 37 69
Other 0 4

Total 127 103
Yakhak Hoeji 2021;65:1-9 https://doi.org/10.17480/psk.2021.65.1.1
© 2021 Yakhak Hoeji